← IndicationsOpen filtered programs
Landscape
Auditory Neuropathy
Auditory Neuropathy has 6 tracked records across 6 named organizations, including 5 strong-evidence records and 5 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.
6
Pipeline Records
strong evidence + caveats + candidates
5
Strong Evidence
1 checked records with caveats
5
Active Programs
currently active
1
Marketed / Approved
commercial or approved
6
Organizations
companies, sponsors, and institutions
Competitive Density
17/100
organization breadth + program volume
Pipeline Velocity
63/100
active and late-stage share
Evidence Coverage
83/100
share strong evidence
Completion Signal
33/100
late-stage, approved, or marketed
Attrition Rate
0/100
share discontinued
Concentration
17/100
top-organization share
Programs by Stage
Preclinical1 · 17%
Phase 1/23 · 50%
Phase 21 · 17%
Approved1 · 17%
Trial / Program Status
Active5 · 83%
Approved1 · 17%
Modality Breakdown
Gene Therapy4 · 67%
Cell Therapy2 · 33%
Program Types
Therapeutic6 · 100%
Top Organizations
Eli Lilly and Company1 · 17%
Lineage Cell Therapeutics1 · 17%
Regeneron Pharmaceuticals1 · 17%
Rinri Therapeutics1 · 17%
Sensorion1 · 17%
Shanghai EuHearing Therapeutics Co., Ltd1 · 17%
Population Tags
adult4 · 67%
bilateral4 · 67%
congenital4 · 67%
genetic4 · 67%
otof-dfnb94 · 67%
pediatric4 · 67%
pre-lingual3 · 50%
profound3 · 50%
auditory-neuropathy2 · 33%
age-related1 · 17%
Strong-Evidence Programs
5 recordsOtarmeni by RegeneronStrong evidence
Company: Regeneron Pharmaceuticals · Approved · Approved
Gene TherapyApprovedApproved99% confidence
AK-OTOF by Eli Lilly and AkouosStrong evidence
Company: Eli Lilly and Company · Phase 2 · Active
Gene TherapyPhase 2Active95% confidence
SENS-501 by SensorionStrong evidence
Company: Sensorion · Phase 1/2 · Active
Gene TherapyPhase 1/2Active94% confidence
Rincell-1 by Rinri TherapeuticsStrong evidence
Company: Rinri Therapeutics · Phase 1/2 · Active
Cell TherapyPhase 1/2Active92% confidence
ReSonance by Lineage Cell TherapeuticsStrong evidence
Company: Lineage Cell Therapeutics · Preclinical · Active
Cell TherapyPreclinicalActive87% confidence